Commentary on the NIH Consensus Development Statement(1) from the Meeting on November 17-19, 1997 Effective Medical Treatment of Heroin Addiction

The National Alliance of Methadone Advocates supports the NIH Consensus

Statement on Effective Treatment of Heroin Addiction that was facilitated by the

National Institute on Drug Abuse and the National Institute of Health.

The imprecate of this special statement should be understood in order to

realize the impact that it can have on methadone maintenance treatment. The

Consensus Statements are prepared by a special committee who are comprised of

individuals who are typically professionals from the disciplines involved in the

issue (i.e. doctors, lawyers, etc.) but they have no connections to the field

being examined. In this respect their conclusions are independent and thus

greater influence. The prepared statement is based on the (1) presentations from

panels consisting of professionals working in the field and relevant areas; (2)

questions and statements from conference attendees during open discussion

periods that are part of the public session; and (3) closed deliberations by The

Committee. Thus the statement is an independent report of the consensus panel

and is not a policy statement of the NIH or the Federal Government.

A Summary of the Recommendations are:

  1. Strong leadership is necessary in educating the public that addiction is

    not self inflicted but is a medical disorder that includes a spectrum of

    brain and medical conditions that can be effectively treated with benefits

    to society.

  2. Society needs to make a commitment to offer effective treatment for heroin

    addiction for all who need it.

  3. Opiate-addicted persons under legal supervision need to have access to

    methadone maintenance treatment.

  4. The training of physicians and other health care professionals need

    improvement regarding the diagnosis and treatment of opiate addiction.

  5. The unwarranted over regulation of methadone maintenance treatment and all

    opiate agonist treatment programs needs to be reduced.

  6. Funding for methadone maintenance treatment needs to be increased and

    required as a benefit for public and private insurance programs equivalent

    to the coverage for all medical and mental disorders.

  7. Chemically dependent pregnant women need to receive special consideration

    and methadone maintenance treatment must be culturally sensitive to enhance

    favorable outcomes for participating African American and Hispanic persons.

  8. Patients, underrepresented minorities, and consumers should be included in

    bodies charged with policy development guiding opiate addiction treatment.

  9. Methadone maintenance treatment needs to be expanded within States and

    regions where programs where it is currently unavailable.

Summary

The Consensus Committee in their full statement emphasized the rigorous

scientific studies that methadone maintenance had undergone over the past 30

years that demonstrate its effectiveness in significantly lowering illicit

opiate drug use, reducing illness and death from illicit opiate drug use,

reducing crime, and by enhancing social productivity. And that in order for

methadone maintenance treatment to receive adequate funding and it’s expansion

be supported it will be necessary to undertake a campaign to educate

politicians, policy makers and society that opiate addiction is a medical

disorder and methadone is effective in treating it.

To replace the regulations The Committee recommended alternatives such as

physician accreditation and certification and to improve education that

physicians, nurses and other health professionals receive. While reducing

regulations will help to promote expansion of methadone maintenance treatment

increased funding is necessary to ensure expansion in all states including those

that do not currently provide it. The Committee strongly recommended that

legislators and regulators recognize the cost effectiveness of methadone

maintenance treatment and that benefits for treatment be part of public and

private insurance programs.

Bodies charged with policy The Committee urged should be include

misrepresented minorities and patients. The Committee stressed that methadone

treatment must be culturally sensitive and that risk groups, such as pregnant

women should be targeted.

What Can Advocates Do?

It is now important for us to ensure that the conclusion of this Consensus

Statement become known by politicians and policy makers. Patients and the family

members of patients should write to their representatives and tell them that

methadone maintenance treatment does work and most important that it saves ad

restores lives. Do not stop at the federal and national level continue writing

and talking with state and local politicians and policy makers. Because

methadone maintenance treatment has been politicized it is at that level that

must first be education. This Consensus Statements give us the chance to promote

and influence the medicalization of methadone maintenance treatment.


1. Effective Medical

Treatment of Heroin Addiction . NIH Consensus Statement 1997 November

17-19;15(6). Available from the National

Clearinghouse for Alcohol and Drug Information NCADI

Back To

Top            The National Alliance Of Methadone Advocates

Similar Posts

  • NAMA Affiliates Pages

    Admin 10/23/2022

    Affiliates Package The first 2 parts of the Affiliates Package are in Ebook format. This means that your computer sees the file as an application and it will have an “exe” file extension. If you click on the file like it is an application – the Ebook with the documents will open. You can then…

  • Reception

    Admin 08/15/2021

    Welcome to The President’s Office and to the National Alliance for Medication Assisted Recovery or NAMA Recovery. NAMA Recovery has gone through some significant changes in the past few years. We are proud of the MARS Project the first project of its kind that provides recovery services to patients receiving Medication Assisted Treatment (MAT). As…

  • The NAMA Store

    Admin 01/01/2022

                Book of the Month Didn’t Find a Book? Search Amazon.Com’s Catalog 2.5-Million Titles Enter Keyword Or Browse by Subject And Press Go. NAMA is a proud affiliate of Amazon.Com Your purchase helps NAMA! A Classic and the book that started it…… Federal Regulation of Methadone Treatment by Richard A. Rettig and Adam…

  • |

    Buprenorphine Information for Physicians

    Admin 05/07/2023

    Federal Law Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Read the full text: Public Law 106-310, Sec. 3502. Controlled…

  • The First Methadone Advocacy Conference

    Admin 04/25/2022

      Time:  September 26, 1998  9:30 AM to 5 PM Place: Roosevelt Hospital Auditorium  1000 Tenth Avenue  between 58-59th Street  New York City Topics:  A conference for methadone patients and by methadone patients. This important conference gives a voice to the voiceless. Topics discussed will be stigma, prejudice, misunderstandings about methadone, new regulations, physician prescribing…

  • NAMA Talk

    Admin 02/07/2022

    Volumn 2, Number 1 February 15, 2000 Organizational News by Joycelyn Woods The big news as this year and the Millennium closes is that methadone is slowly moving to being an accepted medical treatment. This is only the beginning THE FIRST STEP – and there is still an immense amount of work to be done….